Prolonged reproductive suppression in domestic cats following a booster dose of an anti-GnRH vaccine.
A booster dose of an anti-GnRH vaccine can extend reproductive suppression in domestic cats for up to 720 days, providing a potential alternative to surgical sterilization.
Where it sits
this study against the rest of the gonadorelin (gnrh) corpusSummary and findings
The study evaluated the efficacy and safety of a booster dose of an anti-GnRH vaccine in domestic cats. Twenty-one adult female and seven adult male cats received a primary two-dose series followed by a booster dose at day 300. Reproductive suppression was extended for up to 720 days in some queens, with no pregnancies recorded.
Abstract
Immunocontraception via anti-GnRH vaccination offers a non-surgical alternative for managing reproduction in domestic cats, but data on the long-term efficacy of booster protocols remain limited. The study aims to evaluate the efficacy and safety of administering a booster dose of an anti-GnRH vaccine Improvac™ 300 days after primary immunization to prolong reproductive suppression in domestic cats. Twenty-one adult female cats and seven adult male cats received a primary two-dose series of the anti-GnRH vaccine 30 days apart, followed by a booster dose at day 300. Animals were monitored for 540 to 720 days post-booster. Assessments included physical and ultrasonographic examinations, reproductive behavior, vaginal cytology, testicular volume, penile spine characteristics, reproductive hormone concentrations, and hematological parameters. All animals respond to the treatment. In male cats, the booster dose accelerated reduction in testosterone, testicular volume, and penile spine size compared with primary immunization alone. Reproductive suppression was extended for 420 days in two queens, 450 days in five queens, 690 days in four queens, and 720 days in ten queens. Serum progesterone remained basal, and no pregnancies were recorded. Some animals (n = 22) showed transient loss of appetite, but hematological parameters remained within reference ranges, and no injection-site inflammation or tenderness was detected. Administering a booster dose 300 days post-primary immunization safely and effectively prolongs immunocontraception in both male and female domestic cats, providing a viable long-term alternative to surgical sterilization.
Background
This paper addresses the efficacy of immunocontraception via anti-GnRH vaccination in domestic cats, an area with limited data on long-term booster protocols. Prior studies have indicated that anti-GnRH vaccines can manage reproduction, but the durability of effects following booster doses was not well understood. This study is significant as it explores the potential of a non-surgical alternative for long-term reproductive management in cats.
Methods
The study utilized a cohort of 28 domestic cats (21 female, 7 male) that received a primary two-dose series of the anti-GnRH vaccine 30 days apart, followed by a booster dose at day 300. Monitoring occurred for 540 to 720 days post-booster, with assessments including physical examinations, reproductive behavior, and hormone concentrations.
Results
The primary endpoint observed was that reproductive suppression lasted up to 720 days in ten queens. All animals responded to the treatment, and in male cats, the booster dose led to an accelerated reduction in testosterone and testicular volume. No pregnancies were recorded, and serum progesterone levels remained basal.
Interpretation
The findings suggest that the booster dose of the anti-GnRH vaccine can significantly prolong reproductive suppression in domestic cats, which aligns with some previous findings on immunocontraception. However, the clinical significance of the extended suppression duration and the small sample size limit the generalizability of these results. Further studies with larger populations and longer follow-up are necessary to confirm these findings.
Key findings
- Reproductive suppression extended for 420 days in two queens, 450 days in five queens, 690 days in four queens, and 720 days in ten queens.
- All animals responded to the treatment.
- In male cats, the booster dose accelerated reduction in testosterone, testicular volume, and penile spine size compared with primary immunization alone.
- Some animals (n=22) showed transient loss of appetite.
- Serum progesterone remained basal, and no pregnancies were recorded.
Limitations
- small sample size of 28 cats
- follow-up duration may not fully capture long-term effects
- no control group reported
- no detailed adverse event reporting